Comparing the current results to its competitors, Augmedix Inc reported Revenue increase in the 2 quarter 2024 by 24.81 % year on year. The sales growth was above Augmedix Inc 's competitors' average revenue growth of 1.3 %, achieved in the same quarter.
Augmedix Inc 's Comment on Competition and Industry Peers
The company competes on quality of service, range of services, pricing, and flexibility in accommodating different clinician workflows. Its competitors fall into four main categories, including ambient, real-time draft medical note documentation services that utilize AI and large language models to generate draft medical notes requiring clinician review and editing. The company's product suite offers both real-time synchronous and asynchronous solutions with two-way interactivity, care gap reminders, orders, referrals, and customizable support levels, from no support to full review by medical documentation specialists. Most competitors provide basic notes with limited additional features and generally place a greater documentation burden on clinicians, often at lower prices.
July 19, 2024
In a landmark development poised to revolutionize the healthcare technology landscape, Commure has announced an all-cash acquisition of Augmedix for $2.35 per share. This merger underscores a strategic alignment aimed at propelling the capabilities of both companies in delivering cutting-edge ambient AI solutions across the healthcare spectrum.The acquisition is not just a significant financial transaction but an emblem of Commure s unwavering commitment to enhancing the interface between technology and healthcare. By integrating Augmedix s existing innovations with Commure s robust technological frameworks, the union is set to bridge gaps in healthcare documentation and streamline point-of-care solutions ac...
April 4, 2024
In a groundbreaking collaboration, Augmedix and SADA have joined forces to revolutionize healthcare documentation and streamline data integration at health systems across the United States. This partnership aims to accelerate the scaling efforts for Augmedix s digital health solutions, promoting seamless integration at the point of care and bringing unprecedented efficiency to healthcare providers.Augmedix, a leading provider of remote scribe services, is renowned for pioneering the concept of Ambient Clinical Intelligence (ACI). This innovative technology utilizes natural language processing and machine learning algorithms to capture patient-physician encounters in real-time, allowing physicians to focus on...
American Well Corporation operates as a telehealth platform that connects patients with healthcare providers through video consultations. It partners with health plans, hospitals, and other organizations to offer virtual healthcare services, enabling patients to access affordable and convenient medical care from their homes. The company generates revenue by charging fees for each virtual visit conducted on its platform.
Doximity Inc. operates as an online networking platform for medical professionals, connecting doctors and enabling collaboration through its secure platform. The company primarily generates revenue through its subscription-based services, offering premium features to physicians and healthcare organizations. By building a robust network of verified doctors and providing valuable tools and services, Doximity aims to streamline communication and improve healthcare outcomes.
Teladoc Health Inc is a telehealth company that operates a virtual healthcare delivery platform connecting patients with doctors via video consultations. The company generates revenue by charging patients, employers, and health plans a fee for its on-demand medical services. Teladoc's business model focuses on providing convenient, accessible, and cost-effective healthcare solutions, aiming to reduce the need for in-person doctor visits and improve patient outcomes.
Sources:
Augmedix Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Augmedix Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
